Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing

BACKGROUND: Venous thromboembolism (VTE) frequently occurs in hospitalized patients with coronavirus disease 2019 (COVID‐19). The optimal dose of anticoagulation for thromboprophylaxis in COVID‐19 is unknown. AIMS: To report VTE incidence and bleeding before and after implementing a hospital‐wide in...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelen, Matthias M., Vandenbriele, Christophe, Spalart, Valérie, Martens, Caroline P., Vandenberk, Bert, Sinonquel, Pieter, Lorent, Natalie, De Munter, Paul, Willems, Rik, Wauters, Joost, Wilmer, Alexander, Dauwe, Dieter, Gunst, Jan, Guler, Ipek, Janssens, Stefan, Martinod, Kimberly, Pieters, Griet, Peerlinck, Kathelijne, Verhamme, Peter, Vanassche, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980774/
https://www.ncbi.nlm.nih.gov/pubmed/35415384
http://dx.doi.org/10.1002/rth2.12683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980774/
https://www.ncbi.nlm.nih.gov/pubmed/35415384
http://dx.doi.org/10.1002/rth2.12683

Ejemplares similares